Pulmonary embolism as the primary presentation of IgA vasculitis

  1. Osama Mosalem 1 , 2,
  2. Nora Hernandez Garcilazo 1 , 2,
  3. Yehia Saleh 1 , 3 and
  4. Fawzi Abu Rous 1 , 4
  1. 1 Department of Medicine, Michigan State University, East Lansing, Michigan, USA
  2. 2 Department of Medicine, Sparrow Health System, Lansing, Michigan, USA
  3. 3 Department of Cardiology, Houston Methodist DeBakey Heart and Vascular Center, Houston, Texas, USA
  4. 4 Department of Hematology and Oncology, Henry Ford Health System, Detroit, Michigan, USA
  1. Correspondence to Dr Osama Mosalem; Mosalemo@msu.edu

Publication history

Accepted:04 Aug 2020
First published:27 Aug 2020
Online issue publication:27 Aug 2020

Case reports

Case reports are not necessarily evidence-based in the same way that the other content on BMJ Best Practice is. They should not be relied on to guide clinical practice. Please check the date of publication.

Abstract

A 47-year-old man presented to the emergency department with acute onset of dyspnoea and a week history of painful erythematous rash on both of his legs. CT angiogram of the chest showed saddle pulmonary embolism resulting in right ventricular strain and obstructive shock. Due to the atypical nature of his skin rash, a skin biopsy from one of these lesions was done and came consistent with the diagnosis of IgA vasculitis.

Background

IgA vasculitis (Henoch-Schonlein purpura (HSP)) is a small vessel vasculitis that presents predominantly in the paediatric population and far less common in adults. Thrombotic complications are uncommon in IgA vasculitis, and a few cases have been reported in the literature about coagulation abnormalities, especially in the adult population. Pillebout et al 1 analysed 250 adults with IgA vasculitis; none of them presented with thrombotic complications. Moreover, Li et al 2 conducted a literature review on eight patients with IgA vasculitis who had associated thrombotic complications; pulmonary embolism was not reported. On review of the literature and Medline search, this is the first case describing pulmonary embolism related to IgA vasculitis in an adult patient.

Case presentation

A 47-year-old man with a medical history of type II diabetes mellitus and hypertension presented to the hospital with sudden onset of shortness of breath. He also mentioned that 1 week ago, he noticed swelling of his right leg and a painful erythematous skin rash on both lower limbs.

A review of systems was positive for mild non-specific diffuse abdominal pain of the same duration. He denied smoking, alcohol drinking or illegal drug use. He mentioned that he drinks 3 L of water daily and is physically active at baseline. On physical examination, he was hypotensive with blood pressure 82/40, tachycardiac, tachypneic with a respiratory rate of 35 breaths/min and oxygen saturation 82% on room air. The physical examination showed clear lung sounds. The abdomen was soft, not distended with diffuse tenderness to palpation. Extremities showed reddish to purple, non-blanchable, tender purpuric lesions on both legs and, to a lesser extent, on the right forearm (figure 1).

Figure 1

Reddish to purple purpuric lesions on both legs suggestive of IgA vasculitis.

Investigations

Labs were remarkable for white cell count of 16.0×109/L, platelets 268×109/L, haemoglobin 146 g/L, troponin 95 pg/mL, B-natriuretic peptide 195 pg/mL, C reactive protein 9.4 mg/dL and creatinine 0.84 mg/dL. The international normalised ratio was 1.0 and activated partial thromboplastin time 23 seconds. Antinuclear antibodies (ANA), antidouble-stranded DNA, antineutrophil cytoplasmic antibodies (ANCAs) and hepatitis panels were negative. The ECG showed sinus tachycardia. Bedside echocardiogram showed an ejection fraction of 50%–55%, with moderately dilated right ventricle and mobile echo density noted in the proximal right pulmonary artery consistent with possible pulmonary embolism. Subsequently, CT angiogram (CTA) of the chest showed a large saddle embolus with extensive bilateral pulmonary emboli more marked on the right side (figure 2).

Figure 2

CT angiogram of the chest showing saddle-shaped embolus.

Further workup included an ultrasound of both lower limbs, which showed extensive deep venous thrombosis of the right venous system from the right femoral vein down to the calf venous sinuses. CT of the abdomen also showed mild thickening of the cecum and proximal ascending colon suspicious for mild non-specific colitis. Due to non-thrombocytopenic purpura, with abdominal pain, we had a clinical suspicion of vasculitis. After evaluation by a dermatopathologist, a punch skin biopsy was obtained from the lesions in the right distal posterior upper arm. Direct immunofluorescence study findings showed immune deposits of IgA and C3 in blood vessel walls consistent with an immune complex vasculitis, IgA type (HSP).

Differential diagnosis

Our differential diagnosis for this adult male who presented with acute dyspnoea and hypoxia included the exclusion of cardiac causes such as myocardial infarction, arrhythmias and pulmonary embolism. The diagnosis of pulmonary embolism was achieved based on the specific echocardiogram and CTA findings. Moreover, the skin rash that started 1 week prior raised our suspicion about the correlation between the rash and the pulmonary embolism. We excluded other causes of purpura based on the normal platelet count and coagulation profile. Additionally, the normal ANA, ANCA and hepatitis markers ruled out other causes of vasculitis. The presence of abdominal pain and non-thrombocytopenic purpura in children would make IgA vasculitis on the top of the differential list. However, our patient was an adult without renal disease or arthralgia, which made the diagnosis more challenging. Eventually, we decided to proceed with the skin biopsy to solve the dilemma, that was consistent with the diagnosis of IgA vasculitis.

Treatment

Due to the haemodynamic instability at the time of admission and the presence of right ventricular strain, the patient was given thrombolytic therapy (alteplase), was started on a heparin drip and admitted to the intensive care unit. After 48 hours, the patient was switched to rivaroxaban 15 mg two times per day for 21 days, followed by 20 mg once daily for long term anticoagulation. Due to the presence of abdominal pain, purpuric skin rash and absence of renal involvement, we decided to give a short course of steroids 40 mg for 1 week, then 20 mg for another week and slowly tapered over the course of 2 weeks.

Outcome and follow-up

The patient was discharged home and was instructed to follow-up with a haematologist or his primary care physician for hereditary and acquired thrombophilia workup after completion of the anticoagulation course. By the time of discharge, he reported the resolution of his abdominal pain and slight improvement of his skin lesions. As this was an unprovoked pulmonary embolism in an adult male with a large clot burden, he will likely need indefinite anticoagulation.

Discussion

HSP is an acute, systemic, leucocytoclastic small vessel vasculitis characterised by an immune complex deposition containing IgA. Although up to 90% of cases occur in the paediatric population, in children younger than 10 years of age, HSP is an uncommon cause of vasculitis in adults with clinical presentations usually more severe than the paediatric population.3 Pillebout et al 1 analysed 250 adults with HSP, and common clinical presentations in adults included non-thrombocytopenic palpable purpura, arthritis, gastrointestinal involvement, such as colicky abdominal pain, bleeding and nephropathy. Although thrombotic disease was not identified in this study, it has been described sporadically in literature through case reports, with the majority of cases reported in the paediatric population.2 Li et al 2 conducted a literature review and out of a total of eight patients with HSP who suffered from thrombotic events, none of them presented with pulmonary embolism. HSP has been associated with hyperactivation of the coagulation system and impaired activation of the fibrinolytic system, creating a relatively hypercoagulable state.2 Additionally, few studies found that HSP can cause a mild decrease in factor XIII level and a disturbance in thrombocyte function.4 Moreover, HSP was found to be associated with endothelial dysfunction, especially at the time of diagnosis, which might also contribute to the prothrombotic state.5 Furthermore, some cases have reported the occurrence of antiphospholipid syndrome alongside HSP, which can also result in thrombosis.2

Confirmation of the diagnosis of IgA vasculitis with biopsy is usually needed in adults compared with the paediatric population, where biopsy is reserved for cases with severe renal disease.1 A biopsy can be obtained from the skin lesions or the kidneys if involved. Since HSP resolves spontaneously in 94% of children and 89% of adults, supportive management, including anti-inflammatory drugs, is the mainstay of treatment. The use of non-steroidal anti-inflammatory drugs needs to be closely monitored, though, as it may aggravate gastrointestinal symptoms and should be avoided if renal involvement is present.6 Glucocorticoids can be used to shorten disease duration and reduce the incidence of persistent renal disease.7 In the case of severe illness, including organ or life-threatening complications, corticosteroids alone or in combination with immunosuppressive drugs, can be initiated. A recent meta-analysis showed that immunosuppressive therapy combined with steroids was more efficacious than steroids alone in achieving remission in severe or steroid-resistant IgA vasculitis.8 It's crucial to point out that steroids in IgA vasculitis are also controversial, especially when used in ameliorating abdominal symptoms or preventing renal complications, mainly due to the side effect profile and risk of masking other complications (eg, intussusception). Testing for hereditary (eg, factor V Leiden) or acquired thrombophilia (eg, lupus anticoagulant) was not done in our patient during this hospitalisation, as guidelines recommend against testing in the acute settings of thrombosis or while on anticoagulation as these may alter the levels of the hypercoagulable factors and therefore affect the interpretation of the testing.9 Guidelines suggest delaying the workup after completion of the treatment and/or after stopping Direct-Acting Oraln Anticoagulants (DOACs) for at least 2 days.9 It is worth mentioning that haemodynamically unstable pulmonary embolism with a low risk of bleeding can be managed with thrombolytic therapy, as in the case we presented.10

Our patient was active at baseline, not bedbound, with no known family history of thrombosis or other identifiable risk factors that left IgA vasculitis as the only recognisable event which could have triggered such a severe thrombotic episode. Though rare, venous and arterial thrombosis in the setting of HSP might cause life-threatening complications. Knowledge of this may aid in prompt identification and implementation of proper interventions that could improve patient outcomes.

Learning points

  • IgA vasculitis (Henoch-Schonlein purpura (HSP)) is an uncommon cause of vasculitis in the adult population, and a skin biopsy is essential to achieve the diagnosis.

  • Venous and arterial thrombosis in HSP is rare; however, it might cause life-threatening complications.

  • IgA vasculitis is associated with hyperactivation of the coagulation system, and thus creates a relatively hypercoagulable state.

Footnotes

  • Contributors OM and NHG created the manuscript. YS and FAR reviewed and edited the manuscript.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Patient consent for publication Obtained.

  • Provenance and peer review Not commissioned; externally peer reviewed.

References

Use of this content is subject to our disclaimer